Jaguar Health (JAGX) Current Deferred Revenue (2014 - 2026)
Jaguar Health (JAGX) reported Current Deferred Revenue of $170000.0 for Q1 2026, little changed year-over-year from $170000.0 in Q1 2025, and little changed quarter-over-quarter from $170000.0 in Q4 2025.
Jaguar Health (JAGX) Current Deferred Revenue (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 8 years of Current Deferred Revenue data on file, last reported at $170000.0 in Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $170000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $170000.0 (changed 0.0% YoY), and the FY2025 annual result was $170000.0, changed 0.0% from the prior year.
- Current Deferred Revenue held at $170000.0 in Q1 2026 per JAGX's latest filing, from $170000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $170000.0 in Q1 2024 and troughed at $170000.0 in Q1 2024.
- A 3-year average of $170000.0 and a median of $170000.0 in 2024 frame the typical range for Current Deferred Revenue.
- On a YoY basis, Current Deferred Revenue climbed as much as 0.0% in 2025 and fell as far as 0.0% in 2025.
- A 3-year view of Current Deferred Revenue shows it stood at $170000.0 in 2024, then changed by 0.0% to $170000.0 in 2025, then changed by 0.0% to $170000.0 in 2026.
- Business Quant data shows JAGX's Current Deferred Revenue at $170000.0 in Q1 2026, $170000.0 in Q4 2025, and $170000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170,000.00 |
| Dec 31, 2025 | 170,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 170,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | 170,000.00 |
| Sep 30, 2024 | 170,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Mar 31, 2024 | 170,000.00 |
| Jun 30, 2020 | 1.50 Mn |
| Dec 31, 2017 | 177,389.00 |
| Sep 30, 2017 | 224,448.00 |
| Jun 30, 2017 | 184,674.00 |
| Mar 31, 2017 | 208,258.00 |
| Dec 31, 2016 | 224,454.00 |
| Sep 30, 2016 | 246,235.00 |
| Jun 30, 2016 | 262,666.00 |
| Mar 31, 2016 | 279,065.00 |
| Dec 31, 2015 | 251,936.00 |
| Sep 30, 2015 | 336,712.00 |